| 1978N-0065 | Skin Bleaching Drug Products | |||||||||||||||||||||||
| FDA Comment Number : | EC114 | |||||||||||||||||||||||
| Submitter : | Dr. Kathryn Holloway | Date & Time: | 12/07/2006 11:12:21 | |||||||||||||||||||||
| Organization : | Ocala Dermatology and Skin Cancer Center | |||||||||||||||||||||||
| Category : | Health Professional | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Please review carefully the science. Hydroquinones are very valuable to treat a variety of disorders associated with hyperpigmentation including melasma, postinflammatory hyperpigmentation, lentigines, among others. It would be a great disservice to limit access to this effective treatment.
Thank you | ||||||||||||||||||||||||